Hudson Bay Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,000
| Closed | -$1.42M | – | 1095 |
|
|
2021
Q3 | $1.42M | Sell |
25,000
-50,000
| -67% | -$2.84M | 0.02% | 671 |
|
|
2021
Q2 | $3.3M | Buy |
75,000
+20,000
| +36% | +$880K | 0.04% | 458 |
|
|
2021
Q1 | $2.71M | Sell |
55,000
-9,600
| -15% | -$474K | 0.03% | 465 |
|
|
2020
Q4 | $2.72M | Buy |
64,600
+19,600
| +44% | +$825K | 0.03% | 314 |
|
|
2020
Q3 | $2.06M | Buy |
45,000
+40,254
| +848% | +$1.84M | 0.03% | 336 |
|
|
2020
Q2 | $238K | Buy |
+4,746
| New | +$238K | ﹤0.01% | 415 |
|